Evolocumab - CAS 1256937-27-5

Evolocumab is an inhibitor of the humanized monoclonal antibody PCSK9. It binds to circulating PCSK9 protein, resulting in inhibition of PCSK9 binding to LDLR. It can be used in studies of hypercholesterolemia and atherosclerotic cardiovascular disease.

Others, LDLR, NF-κB, TLR, Serine Protease

Immunology/Inflammation, Metabolism, NF-κB, Proteases/Proteasome, Others

1256905

0.983

-20°C

Ice Packs

Inhibitory Antibodies